LYPD3 Antibody (YA1295)

(Synonyms: MIG-C4, Matrigel-induced gene C4 protein, LYPD3, C4.4A)
Customer Review

Based on 1 Customer Validation

LYPD3 Antibody (YA1295) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to LYPD3.

For research use only. We do not sell to patients.
  • Host:

    Rabbit

  • Isotype:

    IgG

  • Application:

    WB, IHC-P, ICC/IF, IP

  • Reactivity :

    Human

  • Formulation:

    Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide and 0.05% BSA.

  • Conjugation:
    Non-conjugated

Applications

Application
WB Info
WB: Western Blot
IHC-P Info
IHC-P: Immunohistochemistry-Paraffin
ICC/IF Info
ICC/IF: Immunocytochemistry/
Immunofluorescence
Dilution Ratio 1:500-1:2000 1:200-1:1000 1:50

Product Details

Description

LYPD3 Antibody (YA1295) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to LYPD3.

  • Host Rabbit
  • Clonality Recombinant,Monoclonal
  • Species Reactivity
    Human
  • Observed Molecular Weight
    Observed band size:90 kDa Info
    Note: Due to possible protein modifications or aggregation, the molecular weight should be confirmed by actual measurement, and the predicted value is for reference only.
  • Calculated Molecular Weight Predicted band size: 36 kDa
Species Reactivity Database

Entrez Gene: 27076 Human

SwissProt: O95274 Human

Immunogen

Peptide

Sensitivity

Endogenous

Purification

Protein A

Conjugation

Non-conjugated

Modification

Unmodified

Isotype

IgG

RRID

AB_3103662

Product Properties

  • Appearance

    Liquid

  • Formulation

    Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide and 0.05% BSA.

  • Concentration

    Batch-dependent, Please check the COA for the concentration of each lot. Check Lot Concentration

  • Storage & Stability

    Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.

  • Shipping

    Shipping with blue ice.

Verification Images

  • Experimental Validation Results for LYPD3 Antibody (YA1295)
    Western blot analysis of extracts from A431(lane 2(20μg) , MCF-7(lane 3(20μg) ,SK-BR-3(lane 4(20μg)and HepG2( lane 5(20μg) using LYPD3 Antibody (HY-P81550). Proteins were transferred to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody ( 1/1000) and Loading control antibody (Beta Actin, HY-P80993,1/10000) was used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Rabbit IgG-HRP Secondary Antibody (HY-P8001,1/10,000) was used for 1 hour at room temperature.
  • Experimental Validation Results for LYPD3 Antibody (YA1295)
    Immunohistochemical analysis of paraffin-embedded human cervical cancer tissue using LYPD3 Antibody (YA1295). The section was pre-treated using heat mediated antigen retrieval with Tris/EDTA buffer (pH 9.0) for 20 minutes. The tissues were probed with the primary antibody (HY-P81550, 1/100) overnight at 4℃. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with neutral balsam.
  • Experimental Validation Results for LYPD3 Antibody (YA1295)
    Immunohistochemical analysis of paraffin-embedded human skin cancer tissue using LYPD3 Antibody (YA1295). The section was pre-treated using heat mediated antigen retrieval with Tris/EDTA buffer (pH 9.0) for 20 minutes. The tissues were probed with the primary antibody (HY-P81550, 1/100) overnight at 4℃. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with neutral balsam.
  • Experimental Validation Results for LYPD3 Antibody (YA1295)
    Immunohistochemical analysis of paraffin-embedded human esophagus tissue using LYPD3 Antibody (YA1295). The section was pre-treated using heat mediated antigen retrieval with Tris/EDTA buffer (pH 9.0) for 20 minutes. The tissues were probed with the primary antibody (HY-P81550, 1/100) overnight at 4℃. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with neutral balsam.
  • Experimental Validation Results for LYPD3 Antibody (YA1295)
    Immunohistochemical analysis of paraffin-embedded human tonsil tissue using LYPD3 Antibody (YA1295). The section was pre-treated using heat mediated antigen retrieval with Tris/EDTA buffer (pH 9.0) for 20 minutes. The tissues were probed with the primary antibody (HY-P81550, 1/100) overnight at 4℃. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with neutral balsam.
  • Experimental Validation Results for LYPD3 Antibody (YA1295)
    Tyramide signaling amplification based immunofluorescence analysis of paraffin-embedded human cervical cancer tissue using LYPD3 Antibody (YA1295) antibody. The section was pre-treated using heat mediated antigen retrieval with Tris/EDTA buffer (pH 9.0) for 20 minutes. The tissues were probed with the primary antibody (HY-P81550, 1/500) overnight at 4℃. The detection was performed using an HRP conjugated compact polymer and fluorescent tyramide signal amplification system.Immunostaining was performed with Vari Fluor 594 TSA (200×)(HY-D1835). Tissues were counterstained with DAPI (blue) and mounted with Anti-fade fluorescence mounting medium.
  • Experimental Validation Results for LYPD3 Antibody (YA1295)
    Tyramide signaling amplification based immunofluorescence analysis of paraffin-embedded human skin cancer tissue using LYPD3 Antibody (YA1295) antibody. The section was pre-treated using heat mediated antigen retrieval with Tris/EDTA buffer (pH 9.0) for 20 minutes. The tissues were probed with the primary antibody (HY-P81550, 1/500) overnight at 4℃. The detection was performed using an HRP conjugated compact polymer and fluorescent tyramide signal amplification system.Immunostaining was performed with Vari Fluor 594 TSA (200×)(HY-D1835). Tissues were counterstained with DAPI (blue) and mounted with Anti-fade fluorescence mounting medium.
  • Experimental Validation Results for LYPD3 Antibody (YA1295)
    Tyramide signaling amplification based immunofluorescence analysis of paraffin-embedded human esophagus tissue using LYPD3 Antibody (YA1295) antibody. The section was pre-treated using heat mediated antigen retrieval with Tris/EDTA buffer (pH 9.0) for 20 minutes. The tissues were probed with the primary antibody (HY-P81550, 1/500) overnight at 4℃. The detection was performed using an HRP conjugated compact polymer and fluorescent tyramide signal amplification system.Immunostaining was performed with Vari Fluor 594 TSA (200×)(HY-D1835). Tissues were counterstained with DAPI (blue) and mounted with Anti-fade fluorescence mounting medium.
  • Experimental Validation Results for LYPD3 Antibody (YA1295)
    Tyramide signaling amplification based immunofluorescence analysis of paraffin-embedded human tonsil tissue using LYPD3 Antibody (YA1295) antibody. The section was pre-treated using heat mediated antigen retrieval with Tris/EDTA buffer (pH 9.0) for 20 minutes. The tissues were probed with the primary antibody (HY-P81550, 1/500) overnight at 4℃. The detection was performed using an HRP conjugated compact polymer and fluorescent tyramide signal amplification system.Immunostaining was performed with Vari Fluor 594 TSA (200×)(HY-D1835). Tissues were counterstained with DAPI (blue) and mounted with Anti-fade fluorescence mounting medium.

Background

  • Function

    LYPD3 supports cell migration. May be involved in urothelial cell-matrix interactions. May be involved in tumor progression

  • Subcellular Localization

    Cell membrane; Lipid-anchor, GPI-anchor

  • Expression


    Tissue_specificity:It is expressed in the placenta, skin, and urothelial cells. It is found in keratinocytes in the basal layer of chronic wounds. It is weakly expressed in esophageal and peripheral blood mononuclear cells. It is found in most primary and metastatic transitional cell carcinomas (TCCs) and breast cancer tissues, but not in adjacent normal tissues. High expression is found in tumor components of some non-invasive superficial lesions, as well as in invasive and metastatic urothelial carcinomas.

    Induction:Up-regulated in migrating keratinocytes during epithelization of incisional skin wounds

  • Subunit

    Binds laminin-1 and laminin-5. Interacts with LGALS3 (By similarity). Interacts with AGR2 and AGR3

  • SwissProt ID

    O95274

  • Gene ID
  • Synonyms

    MIG-C4, Matrigel-induced gene C4 protein, LYPD3, C4.4A

  • Research Field

    Cell biology

LYPD3 Antibody (YA1295) Related Classifications

MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00